198
Views
0
CrossRef citations to date
0
Altmetric
Commentary

Can rituximab unlock the innate potential of checkpoint blockade in the CNS?

Pages 281-283 | Received 05 Aug 2018, Accepted 05 Aug 2018, Published online: 06 Sep 2018
 

Acknowledgments

This work was supported by the Leukemia & Lymphoma Society, by NIH R01CA139-83-01A1 and by Sandler Program for Breakthrough Biomedical Research.

Potential conflict of interest

Disclosure forms provided by the authors are available with the full text of this article online at http://doi.org/10.1080/10428194.2018.1510496.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.